4.5 Article

Differential Incidence of Malaria in Neighboring Villages in a High-Transmission Setting of Southern Mali

Journal

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
Volume 106, Issue 4, Pages 1209-1214

Publisher

AMER SOC TROP MED & HYGIENE
DOI: 10.4269/ajtmh.21-0788

Keywords

-

Funding

  1. European and Developing Countries Clinical Trial Partnership
  2. Medicines for Malaria Venture (Geneva, Switzerland)
  3. DELTAS Africa Initiative [107740/Z/15/Z]
  4. New Partnership for Africa's Development Planning and Coordinating Agency
  5. Wellcome Trust [107740/Z/15/Z]
  6. UK government

Ask authors/readers for more resources

A study conducted in a high-transmission setting in Mali found significant heterogeneity in the number of clinical episodes of malaria, with age, residence, and treatment regimen identified as risk factors. Fine-mapping malaria risks at subdistrict levels is crucial for targeted and customized interventions.
Throughout a phase IIIb/IV efficacy study of repeated treatment with four artemisinin-based combination therapies, significant heterogeneity was found in the number of clinical episodes experienced by individuals during the 2-year follow-up. Several factors, including host, parasite, and environmental factors, may contribute to the differential malaria incidence. We aimed to identify risk factors of malaria incidence in the context of a longitudinal study of the efficacy of different artemisinin-based combination therapy regimens in Bougoula-Hameau, a high-transmission setting in Mali. Risk factors including age, residence, and treatment regimen were compared among individuals experiencing eight or more clinical episodes of malaria (high-incidence group) and individuals experiencing up to three clinical episodes (low-incidence group). Consistent with the known association between age and malaria risk in high-transmission settings, individuals in the high incidence group were significantly younger than individuals in the low-risk group (mean age, 7.0 years versus 10.6 years, respectively; t-test, P < 0.0001). Compared with individuals receiving artemether-lumefantrine, those receiving artesunate-amodiaquine had greater odds of being in the high-incidence group (odds ratio [OR], 2.24; 95% CI, 1.03 - 4.83, P = 0.041), while individuals receiving dihydroartemisinin-piperaquine had a lower odds of being in high incidence group (OR: 0.30, 95% CI, 0.11-0.85; P = 0.024). Individuals residing in the forested areas of Sokourani and Karamogobougou had significantly greater odds of being in the high-incidence group compared with individuals residing in the semi-urban area of Bougoula-Hameau 1 (Karamogobougou: OR, 3.68; 95% CI, 1.46-9.31; P = 0.0059; Sokourani: OR, 11.46; 95% CI, 4.49-29.2; P < 0.0001). This study highlights the importance of fine-mapping malaria risks even at subdistrict levels for targeted and customized interventions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available